
Angibloc 12.5mg Tablet ER
Marketer
Alkem Laboratories Ltd
Salt Composition
Metoprolol Succinate (12.5mg)
Overview Angibloc 12.5mg Tablet ER
CardioBlock 12.5mg Extended-Release tablets are a beta-blocker medication used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medicine also aids in migraine prevention and reduces the risk of future strokes and myocardial infarctions. CardioBlock 12.5mg ER may be administered independently or in conjunction with other therapies; dosage and frequency are determined by your specific condition and treatment goals. It can be ingested with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may take several weeks to manifest, and continuous use, even with symptom improvement, is generally necessary. Discontinuing treatment can exacerbate underlying conditions. Common, usually transient, side effects include fatigue, cephalalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, lightheadedness, and nausea. Less frequent adverse effects may include dyspnea and hypotension. Gradual dose escalation is standard practice to minimize side effects. Report persistent or bothersome side effects to your physician. Prior to initiating treatment, disclose any hepatic impairment to your doctor. CardioBlock 12.5mg ER is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Consult your physician before use during pregnancy or lactation. Individual suitability should be assessed by your doctor, who should also monitor your blood pressure to gauge treatment effectiveness. Alcohol consumption should be minimized due to the potential for increased side effect occurrence.
Uses of Angibloc 12.5mg Tablet ER
Managing angina pectoris (chest discomfort due to heart issues)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Hypertension (high blood pressure) management|Migraine prophylaxis
Major Benefits of Angibloc 12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Angibloc 12.5mg Extended-Release tablet whole; do not crush, chew, or break it. While this medication can be taken with or without food, consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and red meat, when taking Angibloc 12.5mg Tablet ER.
Common Side effects of Angibloc 12.5mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Angibloc 12.5mg Tablet ER:
Consume Angibloc 12.5mg Extended-Release tablets precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. While this medication can be taken with or without food, consistent timing is recommended. Limit consumption of Angibloc 12.5mg ER tablets with meals high in fat, including those containing olive oil, nuts (especially Brazil nuts), dark chocolate, butter, or meat.
How Angibloc 12.5mg Tablet ER works:
Cardiobloc Extended Release 12.5mg tablets are a sustained-action beta-adrenergic blocker targeting cardiac function. The medication reduces heart rate and enhances the heart's pumping efficiency, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Angibloc 12.5mg Extended-Release Tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Angibloc 12.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Angibloc 12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Angibloc 12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Angibloc 12.5mg tablets are considered safe for use in individuals with renal impairment. No alteration to the Angibloc 12.5mg extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Angibloc 12.5mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Angibloc 12.5mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Angibloc 12.5mg Tablet ER :
Should you forget to take your Angibloc 12.5mg Extended-Release Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Angibloc 12.5mg Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Ethyl alcohol and phenolic compounds |
| Potential for Dependence | None. |
| Medication Category | Heart-related |
